The safety of immune globulins.
Tepper
M
M
Blood-borne Pathogens Division, Bureau of Infectious Diseases, LCDC, Ottawa, Ontario.
Gully
P
P
D004345:Drug Industry; D015658:HIV Infections / Q000635:transmission*; D006509:Hepatitis B / Q000635:transmission*; D006526:Hepatitis C / Q000635:transmission*; D006801:Humans; D007136:Immunoglobulins / Q000009:adverse effects*; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D017053:Infection Control; D007273:Injections, Intramuscular
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous